Trials / Completed
CompletedNCT02132936
LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 504 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose is to compare the efficacy of treatment with LEO 90100 at Week 4 to that of calcipotriol plus betamethasone dipropionate (BDP) gel at Week 8 in subjects with psoriasis vulgaris
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LEO 90100 aerosol foam | |
| DRUG | Aerosol foam vehicle | |
| DRUG | Calcipotriol BDP gel | |
| DRUG | Gel vehicle |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2014-05-07
- Last updated
- 2025-03-10
- Results posted
- 2016-05-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02132936. Inclusion in this directory is not an endorsement.